Dr. Durre Nayab – Cancer Research – Best Researcher Award

Posted on 27/02/202428/02/2024 by Pencis

Dr. Durre Nayab - Cancer Research - Best Researcher Award

Technische Universitat Dresden - Germany

AUTHOR PROFILE

EARLY ACADEMIC PURSUITS:

Durr-e-Nayab's academic journey began with a Bachelor's degree in Computer Systems Engineering from the University of Engineering and Technology, Peshawar, Pakistan, followed by a Master's in Computer Systems Engineering from the same institution. Later, she achieved a Ph.D. in Electrical Engineering from the University of Engineering and Technology, Peshawar, with a research focus on Adaptive Expanding Ring Search Based Per Hop Routing Rendition in Mobile Ad Hoc Networks (MANETs) using Machine Learning.

PROFESSIONAL ENDEAVORS:

Nayab has accumulated 11 years of teaching experience and 6 years of research experience. She has held various positions, including Lecturer & Batch Advisor at the University of Engineering and Technology, Peshawar, and Research Assistant at the Center for Intelligent Systems and Networks Research. Additionally, she has served as a Lecturer in Computer Science at City University of Science and Technology and Institute of Business and Management Sciences.

CONTRIBUTIONS AND RESEARCH FOCUS ON CANCER RESEARCH

Her contributions extend to research projects, including a significant role as a Research Assistant in R & D Funded Projects at the Center for Intelligent Systems and Networks Research. Notable projects involve secure and intelligent transportation systems, secure billing frameworks, traffic pattern analysis, and autonomous situation-based alerts using wireless sensor networks.

IMPACT AND INFLUENCE:

Dr. Nayab's impact is evident through her contributions to projects funded by ICT R & D, Ministry of IT Pakistan, addressing critical issues such as congestion control, electricity theft, and traffic patterns in Pakistan. Her role as a Co-PI at the National Center for Artificial Intelligence showcases her influence in shaping intelligent systems design in Pakistan.

ACADEMIC CITES:

Dr. Nayab's research has made a substantial impact, with publications in reputable journals, including "Applied Computational Intelligence and Soft Computing," "Annals of Telecommunication," and "Computers, Materials & Continua."

LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Nayab's legacy is marked by her dedication to research and education, particularly in the fields of Mobile Ad Hoc Networks, Machine Learning, and Artificial Intelligence. Her future contributions are anticipated in her role as a Post-Doctoral Researcher at TU Dresden, focusing on Transport Modeling, Cancer Research and Simulation.

NOTABLE PUBLICATIONS

Performance Augmentation of Base Classifiers Using Adaptive Boosting Framework for Medical Datasets. 2023

Effects of dataset attacks on machine learning models in E-health. 2023

SP-DSTS-MIMO Scheme aided H.266 for reliable high data-rate mobile video-communication. 2023

Data Augmentation and Random Multi-Model Deep Learning for Data Classification. 2022

Sparse Crowd Flow Analysis of Tawaaf of Kaaba during the COVID-19 Pandemic. 2022

Prof. Rami Nassir – Cancer Genetics – Best Researcher Award

Posted on 16/02/202416/02/2024 by Pencis

Prof. Rami Nassir - Cancer Genetics - Best Researcher Award

Pathology - School of Medicine - Umm AlQura University - Saudi Arabia

AUTHOR PROFILE

Scopus

Orcid

Google Scholar

EARLY ACADEMIC PURSUITS:

Rami M. Nassir, Ph.D., embarked on his academic journey at the University of California, Davis, focusing on Comparative Pathology with a major in Human Genetics. His early academic pursuits set the stage for a distinguished career at the intersection of genetics, pathology, and complex diseases.

PROFESSIONAL ENDEAVORS:

Nassir has seamlessly integrated academia, research, and clinical practice. Currently serving as a Professor (since July 2022) at the School of Medicine, Umm Al-Qura University, he is actively engaged in providing lectures across various pathology courses, supervising laboratory research, and contributing to small clinical research projects.

CONTRIBUTIONS AND RESEARCH FOCUS ON CANCER GENETICS

Rami M. Nassir's research focus spans diverse areas, including whole-genome sequencing, molecular diagnostics,cancer genetics and clinical applications in genomic medicine. His significant contributions to various sequencing platforms and meta-analyses underscore his dedication to advancing genetic research methodologies.

IMPACT AND INFLUENCE:

Nassir's impact extends beyond academia into clinical practice. His involvement in diagnosing rare genetic diseases, implementing genomic medicine in diagnostic centers, and contributing to IVF procedures demonstrates the practical application of his research.

ACADEMIC CITES:

Being a member of prestigious genetic and medical societies such as the American Society of Human Genetics and the Saudi Society for Genomics and Molecular Oncology reflects Nassir's recognition in the academic community.

LEGACY AND FUTURE CONTRIBUTIONS:

Nassir's legacy lies in his extensive research accomplishments, including his work in next-generation sequencing, meta-analyses, and population stratifications. His commitment to advancing research methodologies positions him as a trailblazer in the field.

RESEARCH ACCOMPLISHMENTS:

His proficiency in various genetic analysis techniques, from SNP genotyping to statistical analysis, highlights Nassir's comprehensive skill set and its application in contributing to major studies.

NOTABLE PUBLICATIONS

Racial and Ethnic Differences in Self-Reported COVID-19 Exposure Risks, Concerns, and Behaviors Among Diverse Participants in the Women's Health Initiative Study. 2023

Genetic control of mRNA splicing as a potential mechanism for incomplete penetrance of rare coding variants. 2023

A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk. 2023

Race and Ethnicity and Fracture Prediction among Younger Postmenopausal Women in the Women's Health Initiative Study. 2023

Associations of maternal preterm birth with subsequent risk for type 2 diabetes in women from the women's health initiative. 2023

Prof. Wenhao Ouyang – Tumor Immunology – Best Researcher Award

Posted on 15/02/202415/02/2024 by Pencis

Prof. Wenhao Ouyang - Tumor Immunology - Best Researcher Award

Sun Yat-Sen Memorial Hospital - China

AUTHOR PROFILE

Scopus

EARLY ACADEMIC PURSUITS:

Wenhao Ouyang commenced his academic journey at Sun Yat-sen University, delving into the field of Medical Oncology. His early academic pursuits laid the foundation for a career marked by dedication to advancing cancer research and treatment.

PROFESSIONAL ENDEAVORS:

As a Physician and Ph.D. Candidate at Sun Yat-sen Memorial Hospital, Wenhao Ouyang's professional endeavors center around tumor big data, artificial intelligence research, tumor immunology, and immunotherapy research. His dual role as both a clinician and researcher highlights his commitment to bridging the gap between clinical practice and cutting-edge research.

CONTRIBUTIONS AND RESEARCH FOCUS ON TUMOR IMMUNOLOGY

Wenhao Ouyang has made substantial contributions to the field through his research, focusing on tumor big data, artificial intelligence, and tumor immunology. His published articles in esteemed journals showcase the depth and breadth of his research, with a focus on prognostic factors, immunotherapy response, and the tumor microenvironment.

IMPACT AND INFLUENCE:

Ouyang's impact is evident through his published articles, each addressing critical aspects of cancer research. His work, such as developing prognostic risk scores and identifying immune-inflammation signatures, reflects his influence on shaping the understanding of cancer prognosis and treatment response.

ACADEMIC CITES:

Being a reviewer for Frontiers in Immunology underscores Wenhao Ouyang's standing in the academic community. Reviewing articles in this reputable journal demonstrates his expertise and recognition within the field, contributing to the advancement of scientific knowledge.

LEGACY AND FUTURE CONTRIBUTIONS:

Wenhao Ouyang's legacy is unfolding through a substantial body of work that has already left a mark on cancer research. His role as a major participant in the selection of articles for the 2023 ESMO Asia poster highlights his commitment to sharing knowledge and advancing the field on a global scale.

HIGHLIGHT OF FUTURE CONTRIBUTIONS:

Looking forward, Ouyang's involvement in groundbreaking projects, such as multimodal data fusion for improved risk stratification of breast cancer, signals a trajectory of continued impact. His role in precision neoadjuvant chemotherapy and distinguishing tumor immunotyping heterogeneity positions him as a key figure in shaping the future of cancer research and treatment.

NOTABLE PUBLICATION

Immune gene patterns and characterization of the tumor immune microenvironment associated with cancer immunotherapy efficacy. 2023 (1)

Machine learning radiomics of magnetic resonance imaging predicts recurrence-free survival after surgery and correlation of LncRNAs in patients with breast cancer: a multicenter cohort study. 2023 (1)

Identification of a tumor immune-inflammation signature predicting prognosis and immune status in breast cancer. 2023

A Comprehensive Analysis of Programmed Cell Death-Associated Genes for Tumor Microenvironment Evaluation Promotes Precise Immunotherapy in Patients with Lung Adenocarcinoma. 2023

Prognosis and Immunotherapy Response With a Novel Golgi Apparatus Signature-Based Formula in Lung Adenocarcinoma. 2022 (2)

A Prognostic Risk Score Based on Hypoxia-, Immunity-, and Epithelialto-Mesenchymal Transition-Related Genes for the Prognosis and Immunotherapy Response of Lung Adenocarcinoma. 2022 (19)

Assoc Prof Dr. RAFİYE CİFTCİLER – Targeted Cancer Therapy – Best Review Article Award

Posted on 15/02/202415/02/2024 by Pencis

Assoc Prof Dr. RAFİYE CİFTCİLER - Targeted Cancer Therapy - Best Review Article Award

SELCUK UNIVERSITY FACULTY OF MEDICINE DEPARTMENT OF HEMATOLOGY -Turkey

AUTHOR PROFILE

Scopus

Orcid

Google Scholar

EARLY ACADEMIC PURSUITS:

Rafıye Ciftciler embarked on her academic journey with a strong foundation in medicine and a focus on hematology. She pursued her Medical School education at Hacettepe University Faculty of Medicine, where she laid the groundwork for her future contributions to the field.

PROFESSIONAL ENDEAVORS:

Following her medical education, Rafıye Ciftciler delved into Internal Medicine at Gazi University Faculty of Medicine, broadening her clinical expertise. Subsequently, she specialized in Hematology at Hacettepe University Faculty of Medicine, honing her skills in the intricate field of blood disorders.

CONTRIBUTIONS AND RESEARCH FOCUS ON TARGETED CANCER THERAPY

Rafıye Ciftciler has significantly contributed to the science of hematology, with approximately 100 publications to her name. Her research encompasses a diverse range of topics within hematology, showcasing her dedication to advancing knowledge in the field.

IMPACT AND INFLUENCE:

Her impact extends beyond publications, as evidenced by her accolades. The Young Researcher Award from the Turkish Society of Hematology at the 44th National Hematology Congress and the Oral Presentation Award at the 3rd National Blood and Bone Marrow Transplant Congress underscore her influence in the academic and scientific community.

ACADEMIC CITES:

Rafıye Ciftciler's work has likely garnered attention within the academic community, reflected in her certifications from esteemed organizations like the European Hematology Association and the Turkish Hematology Association. These certifications affirm her proficiency and recognition in the broader scientific arena.

LEGACY AND FUTURE CONTRIBUTIONS:

As an Associate Professor in the Department of Hematology at Selcuk University Faculty of Medicine, Rafıye Ciftciler has already established a commendable legacy. Her continuous contributions to the science of hematology and her role in shaping the next generation of medical professionals mark her as a key figure in the field.

HIGHLIGHT OF FUTURE CONTRIBUTIONS:

Looking ahead, Rafıye Ciftciler's future contributions are anticipated to further enrich the field of Targeted Cancer Therapy. Whether through groundbreaking research, mentorship, or educational initiatives, her commitment to advancing knowledge and improving patient care is poised to leave a lasting impact on the discipline.

NOTABLE PUBLICATIONS

Efficacy and Safety of Immune Checkpoint Inhibitors in Hematologic Malignancies. 2024

The Effect of Obesity and Body Mass Index on Hematologic Malignancies. 2023

Hereditary thrombocytopenia with familial novel mutation in MYH9 gene: A familial case report. 2023

Immune Thrombotic Thrombocytopenic Purpura in Elderly Patients: The Roles of PLASMIC and French Scores. 2023

Dr. Fatemeh Kanaani Nejad – Breast Cancer Screening – Best Researcher Award

Posted on 14/02/202415/02/2024 by Pencis

Dr. Fatemeh Kanaani Nejad - Breast Cancer Screening - Best Researcher Award

Anesthesiology and Critical Care Research Center - Iran

Author Profile

Google Scholar

EARLY ACADEMIC PURSUITS:

Fatemeh Kanaani Nejad was an academically driven individual from early on, demonstrating her commitment to education during her high school years at Farzanegan High School in Shiraz, Iran (2011-2014). Her consistent dedication and performance laid the foundation for her subsequent academic journey.

PROFESSIONAL ENDEAVORS:

After completing high school, Fatemeh pursued her Medical Doctor (MD) degree at Isfahan University of Medical Sciences, Isfahan, Iran, from February to July 2015. She continued her medical education at Shiraz University of Medical Sciences, Shiraz, Iran, graduating in February 2022. Following her academic achievements, she embarked on a postdoctoral research position at the Anesthesiology and Critical Care Research Center, Shiraz University of Medical Sciences, starting in September 2022.

CONTRIBUTIONS AND RESEARCH FOCUS ON BREAST CANCER SCREENING

Fatemeh actively engaged in various workshops and certifications, showcasing her commitment to expanding her skill set. Notably, she participated in workshops such as Search, Study Design, and Proposal Writing, as well as Python training. Her research focus, primarily in the field of Anesthesiology and Critical Care, is evident in her contributions to poster presentations for the European Society of Radiology (ECR 2023). These contributions cover topics ranging from targeted ultrasound of the breast to the application of shear wave elastography in breast cancer screening.

IMPACT AND INFLUENCE:

Fatemeh's impact extends beyond her academic pursuits. Her poster presentation on "Anti-Inflammatory Therapy in Hair Loss Treatment" at The Second International Conference on Holly Prophet Mohammad’s Tradition reflects her engagement with interdisciplinary topics and potential implications for medical treatments.

ACADEMIC CITES:

While specific citation numbers are not provided, Fatemeh's work is disseminated through DOI-linked poster presentations. This suggests that her research is accessible and has the potential for citation within the academic community.

LEGACY AND FUTURE CONTRIBUTIONS:

Fatemeh's legacy is marked by her achievements as the first-ranked student in Farzanegan high school and the second-ranked student among Isfahan University of Medical Sciences students in 2015. Her mentorship role in the Medical Physics Research Center and continued contributions to conferences indicate a promising future of further academic and professional accomplishments.

NOTABLE PUBLICATIONS

Dr. Linxi Zhu – Cancer Genetics – Best Researcher Award

Posted on 12/02/202414/02/2024 by Pencis

Dr. Linxi Zhu - Cancer Genetics - Best Researcher Award

Nanjing Drum Tower Hospital - China

Author Profile

Scopus

EARLY ACADEMIC PURSUITS:

Linxi Zhu commenced her academic journey at Nanjing University, where she pursued a Bachelor's degree from July 2015 to June 2020. Following her undergraduate studies, she continued her academic pursuit at the same institution, earning a Master's degree from July 2020 to June 2021. Linxi Zhu then advanced further in her educational journey, undertaking a Ph.D. program at Nanjing University from July 2021 to June 2023.

PROFESSIONAL ENDEAVORS:

Since September 2023, Linxi Zhu has been serving as a Surgeon at Nanjing Drum Tower Hospital, marking a significant transition from academic pursuits to practical application in the field of surgery.

CONTRIBUTIONS AND RESEARCH FOCUS ON CANCER GENETICS :

Linxi Zhu's research has made notable contributions to the field of cancer genetics. Notably, her work titled "Loss of Claudin-1 incurred by DNMT aberration promotes pancreatic cancer progression" (published in Cancer Lett., 2024) sheds light on the molecular mechanisms underlying pancreatic cancer progression. Additionally, she has contributed to the development and validation of a nomogram for predicting post-operative abdominal infection in patients undergoing pancreaticoduodenectomy, as well as exploring the role of preoperative biliary drainage in postoperative outcomes after pancreaticoduodenectomy.

IMPACT AND INFLUENCE:

Zhu's research impact extends beyond pancreatic cancer, with contributions to the field of intrahepatic cholangiocarcinoma. Her collaborative work on high endothelial venule as a prognostic immune-related biomarker in patients with resected intrahepatic cholangiocarcinoma (published in Cell Prolif., 2023) underscores her diverse research interests.

ACADEMIC CITES:

Linxi Zhu has published in reputable journals, evident from her publications in Cancer Lett., Clin Chim Acta, Gland Surg, Cell Prolif., and Front Oncol. The citations received for her work demonstrate its scholarly significance and recognition within the academic community.

LEGACY AND FUTURE CONTRIBUTIONS:

Zhu's legacy lies in her comprehensive understanding of pancreatic cancer and related surgical interventions. Her research on individualized chemotherapy combined with sequential immunotherapy based on BRCA1 mRNA expression level in unresectable pancreatic cancer showcases innovative approaches. Looking forward, Linxi Zhu is poised to contribute further to the field, leaving a lasting impact on surgical and oncological research.